China Universal Asset Management Company’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Buy |
19,430
+102
| +0.5% | +$903 | 0.02% | 324 |
|
|
2025
Q1 | $151K | Sell |
19,328
-1,104
| -5% | -$8.64K | 0.01% | 333 |
|
|
2024
Q4 | $215K | Buy |
20,432
+1,916
| +10% | +$20.1K | 0.02% | 320 |
|
|
2024
Q3 | $243K | Buy |
18,516
+7,224
| +64% | +$94.7K | 0.03% | 281 |
|
|
2024
Q2 | $159K | Buy |
+11,292
| New | +$159K | 0.02% | 267 |
|
|
2024
Q1 | – | Sell |
-10,327
| Closed | -$146K | – | 442 |
|
|
2023
Q4 | $146K | Buy |
10,327
+8,029
| +349% | +$113K | 0.03% | 243 |
|
|
2023
Q3 | $23.7K | Buy |
2,298
+1,454
| +172% | +$15K | 0.01% | 289 |
|
|
2023
Q2 | $13.9K | Sell |
844
-7
| -0.8% | -$115 | ﹤0.01% | 300 |
|
|
2023
Q1 | $7.8K | Buy |
851
+233
| +38% | +$2.13K | ﹤0.01% | 324 |
|
|
2022
Q4 | $4.43K | Buy |
618
+66
| +12% | +$473 | ﹤0.01% | 311 |
|
|
2022
Q3 | $3K | Buy |
+552
| New | +$3K | ﹤0.01% | 320 |
|